Ann: Half-Year Investor Presentation, page-27

The pivotal trial will commence in early 2023 and take place in the US, Europe & Australia. Lots of people to sign up, and most important, exposure to the masses as it pertains to investors outside of Australia & New Zealand. I've been saying this for 4 years now, and the rubber is about to grip the road. This exposure & awareness to these large new investor markets will have a significant impact on the PPS at a crucial time. And don't forget, Imagion will sign a manufacturing partner in 2023 and it won't be for peanuts either!
Interesting times lay ahead.